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Background: The study aims at identifying long-term trends and patterns of current smoking by age, gender, and
education in Russia, including the most recent period from 2008 during which tobacco control policies were
implemented, and to estimate the impact on mortality of any reductions in prevalence. We present an in-depth
analysis based on an unprecedentedly large array of survey data.
Methods: We examined pooled micro-data on smoking from 17 rounds of the Russian Longitudinal Monitoring
Study of 1996–2016, 11 other surveys conducted in Russia in 1975–2017, and two comparator surveys from England
and the USA. Standardization by age and education, regression and meta-analysis were used to estimate trends in
the prevalence of current smoking by gender, age, and educational patterns.
Results: From the mid-1970s to the mid-2000s smoking prevalence among men was relatively stable at around
60%, after which time prevalence declined in every age and educational group. Among women, trends in smoking
were more heterogeneous. Prevalence more than doubled above the age of 55 years from very low levels (< 5%).
At younger ages, there were steep increases until the mid-2000s after which prevalence has declined. Trends
differed by educational level, with women in the lowest educational category accounting for most of the long-term
increase. We estimate that the decline in male smoking may have contributed 6.2% of the observed reduction in
cardiovascular deaths among men in the period 2008–16.
Conclusions: The implementation of an effective tobacco control strategy in Russia starting in 2008 coincided with
a decline in smoking prevalence among men from what had been stable, high levels over many decades
regardless of age and education. Among women, the declines have been more uneven, with young women
showing recent downturns, while the smoking prevalence in middle age has increased, particularly among those
with minimal education. Among men, these positive changes will have made a small contribution to the reduction
in mortality seen in Russia since 2005.
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The prevalence of smoking among Russian men has been
very high for many years. The WHO Global Adult To-
bacco Survey (GATS) found that, in the 2000s, it was
among the highest in the world [1] with Russia having the
world’s second-largest tobacco market by volume of sales
in 2014, [2] even though it is home to under 2% of the
world’s population. Encouragingly, over the past 10 years,
there have been a series of policy initiatives to tackle this
major public health problem. Later than most other coun-
tries, in 2008 Russia ratified the Framework Convention
on Tobacco Control [3]. From this point on there has
been an acceleration in policies aimed at reducing smok-
ing. In 2010 the National Strategy on Creation of a Public
Policy to Combat Tobacco Consumption was launched
and in 2012 the Ministry of Health issued a decree to
introduce pictorial health warnings on cigarette packages
from 2013. Most importantly, in 2013 a comprehensive
Federal Tobacco Control Law came into force [4]. This in-
cluded a 100% smoke-free policy in all public places, with
the World Health Organisation (WHO) giving Russia a
score of 7 on a scale of zero to 10 for compliance, a con-
tinued incremental increase in the tax on tobacco prod-
ucts, restrictions on tobacco advertisements (with the
WHO scoring Russia as 10 out of 10 for compliance), pro-
motions, and sponsorship (scoring 8–10 for compliance in
most categories), and strengthened anti-tobacco cam-
paigns in various media outlets [5].
The implementation of these smoking control policies in
Russia overlapped with the longest period of decline in
adult mortality since the 1960s. After a period of rising life
expectancy after the second world war, the mid-1980s saw
the start of massive fluctuations driven mainly by changes
in the prevalence of heavy drinking [6]. However, since the
mid-2000s, life expectancy has steadily increased, due in
particular to declines in mortality from cardiovascular dis-
ease (CVD) and external causes. The reasons for this im-
provement are not fully understood and cannot be
attributed solely to changes in alcohol drinking [7, 8]. An
important question, therefore, arises as to whether the de-
velopment of tobacco control policies since 2008 has con-
tributed to these important declines in mortality. However,
before this question can be answered we need to know
whether smoking prevalence has declined as might be
hoped given the policies introduced.
Monitoring smoking behavior in a population is an im-
portant public health function. Several countries conduct
regular national health and risk-factor monitoring surveys.
They include the National Health and Nutrition Examin-
ation Survey (NHANES) in the United States and the
Health Survey for England (HSE). Russia does not have an
equivalent regular population-based public health moni-
toring survey. Nevertheless, there have been various at-
tempts to measure smoking in Russia, but these have beenbased mainly on research studies. These include the Rus-
sian Longitudinal Monitoring Survey (RLMS) [9, 10], and
several other nationally representative surveys [11–14].
Beyond this, there are a number of geographically specific
epidemiological studies that have collected data on smok-
ing, even if they have not published detailed analyses of
prevalence rates.
Given the importance of looking at whether the recent
development of tobacco control policies in Russia has
accompanied reductions in smoking, as well as the cen-
tral role of smoking as a driver of population health,
there is a strong argument to undertake a synthesis of
all available data sources. Triangulation, whereby one at-
tempts to strengthen the validity of conclusions and in-
ferences, by identifying common patterns from a range
of data generated in different ways, is an obvious ap-
proach to apply to smoking in Russia.
In this paper, we aim to produce the most in-depth and
comprehensive assessment to date of recent trends in
current smoking levels for Russia. We consider whether
there are different trends by age, sex, and educational
level, to inform priorities for future policy. Finally, we con-
sider how far changes in smoking may have contributed
to declines in mortality in Russia that have occurred since
the mid-2000s.
Methods
We used our knowledge of the research literature to
identify potentially useful data sets. We obtained anon-
ymized individual-level data on smoking from studies of
the Russian population. Our criterion for inclusion was
that the data came from surveys that were designed with
the aim of being representative of the general population
of the whole country or of certain cities or regions, in-
cluding those involving multi-stage sampling with pri-
mary sampling units being settlements across the
country. Some of the studies, to a greater or lesser ex-
tent, are likely to be subject to selection bias and will
not be perfectly representative of their target popula-
tions. However, by combining data from a range of dif-
ferent studies, using a variety of sampling frames and
data collection methods, our logic was that any common
patterns that might emerge are likely to reflect the true
prevalence of smoking.
Data sets
In our analysis, we included 17 annual rounds (1996–
2016) of the Russian Longitudinal Monitoring Survey
(RLMS) plus 11 independent cross-sectional studies con-
ducted between 1975 and 2016. RLMS provides the only
continuous time series of smoking in Russia. The RLMS
has a design aimed at producing a nationally representa-
tive sample (average sample size is 7302 in 1996–2009
and 11,634 in 2010–2016). However, there are some
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due to periodic sample replenishments [15]. Replenish-
ment of the 2010 sample was especially significant due to
an immediate 50% enlargement of the sample. In the fol-
lowing years, the observed between-round attrition rates
were substantially higher than those in 2010 and preced-
ing years [15]. Preliminary checks on the data showed that
this temporary distortion also expresses itself in short-
term fluctuations in the prevalence of smoking in age
groups between 25 and 55. For this reason, RLMS rounds
of 2011 and 2012 were excluded from the analysis.
Of the other cross-sectional surveys some have aimed
at national representativeness and coverage. These in-
clude the Living conditions, Lifestyle and Health (LLH)
[12–14] and Health in Times of Transition (HiTT) [14]
surveys, the WHO Study on global AGEing and adult
health (SAGE), the WHO Global Adult Tobacco Survey
(GATS), and the VCIOM “Healthy lifestyle monitoring”.
In addition, we have used other ad hoc epidemiological
studies that have collected data on smoking, although
these are generally restricted to specific geographic loca-
tions i.e. cities. The sample size of these varies from
1109 in Izhevsk Family Study 2 (IFS 2) to 73,548 in the
Monitoring of Arterial Hypertension (Monitoring AH).
While a majority of surveys cover almost the entire
range of adult ages from 18 to about 80, the Stress Aging
and Health Study (SAHR) and SAGE focus on older
ages. The Izhevsk studies IFS 1 and IFS 2 include only
those of working age, from 25 to 60. To put our results
in an international context, we obtained individual-level
data from the 2012 Health Survey for England (HSE) and
from the 2015-2016 US National Health and Nutrition
Examination Survey (NHANES). More details of the stud-
ies included are provided in Table S1 (Additional file 1).
We are aware of several other studies that could have
usefully been included. However, despite approaching
the data holders for access we were unable to obtain
individual-level data. These are the surveys of the epi-
demiology of cardiovascular diseases and their risk fac-
tors in the regions of the Russian Federation (ESSE-RF)
funded by the Russian Ministry of Health, [16] the Pit-
käranta study in the Republic of Karelia [17] and the
Russian component of the HAPIEE study [18].
Smoking questions
The definition of current smoking varies to some degree
across the surveys included in this study (Table S2, Add-
itional file 2). In summary three versions of the current
smoking variable were employed: (1) current smoking as
defined by the WHO; (2) daily smoking according to the
WHO; (3) current smoking based on response to a sim-
ple question as to whether they “currently smoked”. Ac-
cording to the WHO definition, current smoking is the
consumption of any tobacco product either daily or lessfrequently (occasionally) (see also Notes under Table S2
in Additional file 2). This broad definition was used in
four Russian surveys and in NHANES. In the latter U.S.
study, the WHO smoking question was asked only to
those who had smoked at least 100 cigarettes during
their entire lives. Our cross-tabulation of NHANES data
(analysis not shown here) indicates that the 100-
cigarette filtering leads to only a 0.9% understatement of
current smoking compared to the WHO definition. All
RLMS rounds and other five surveys used the conven-
tional question “Do you smoke in the present?” (or “Are
you a current smoker?”). Some of those responding to
this question may have assumed that an affirmative an-
swer corresponds to regular daily smoking but others
might have thought that it also included periodic or epi-
sodic smoking. Our cross-tabulations from GATS,
SAGE, and VCIOM surveys suggest that the share of
smokers who do not smoke every day constitutes 2 to
7% among those who are current smokers according to
the WHO definition. The latter figures reflect a) the
magnitude of understatement of the current smoking in
surveys where daily smoking is available; and b) the
upper limit of the magnitude of understatement of
smoking in RLMS and the other five surveys that used
the conventional question. These values agree well with
the earlier study that assessed the difference in the
smoking prevalence between RLMS and GATS [7].
In HSE, the current smoking variable is based on re-
sponses to the question “Do you smoke any cigarettes at
all nowadays?”. Because of the use of “any” and “at all”
this is essentially equivalent to the WHO definition of
current smoking.
It is important to note that all the RLMS rounds use
the same definition of smoking and in this regard, the
RLMS series is fully consistent.
Statistical analysis
In our main analyses, we adjusted the prevalence of current
smoking for educational level by direct standardization.
The RLMS educational structure between 1996 and 1998
was taken as a standard for adjustment by education. This
was in order to remove the confounding effects of different
educational compositions of the various samples both over
time and geographically. As education, is very likely to be
associated with smoking, the education-adjusted estimates
exclude effects that are simply the result of changes or dif-
ferences in the educational structure of populations. We ex-
amined the age-standardized prevalence of current
smoking, using the European standard population of 1976
which ensures numerical comparability with prevalence es-
timates provided by the WHO “Health for All” Database
[19].
We then turned to the relationship between smoking
and socio-demographic categories over calendar time,
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cross-sectional surveys, paying particular attention to
whether the time trends were the same. This was done
using meta-analytic approaches and where necessary
meta-regressions. This approach anticipates and expli-
citly addresses inter-survey variability of designs and the
effects of these on the heterogeneity of estimates.
Multi-study-based relationships between current smok-
ing and three levels of education (lower, secondary, ter-
tiary) were established for each sex separately by running
the two-stage individual-participant data meta-analysis
(ipdmetan) with the forest plot option in Stata 13 [20].
The method first fits a logistic regression linking the odds
of smoking with education within each study and then es-
timates the pooled effect of education as a weighted aver-
age of study-specific effects. We used a random-effects
model that assumed inverse-variance weights accounting
for within-study variance and between-study variance with
DerSimonian-Laird estimator [21]. The I2 heterogeneity
measure expresses the between-study variance as a per-
centage of the total variance. All these estimates (study-
specific and pooled effects, effects’ confidence limits, vari-
ances and I2 values) are shown in sex-specific forest plots
created using the forestplot package in R [22]. To check
temporal changes in the age-adjusted prevalence of
current smoking for trends, we used the conventional
random-effects meta-regression (metareg) command in
Stata [23].
We assessed a hypothetical impact of the reduction in
male smoking on deaths from CVD in 2008–2016. The es-
timation procedure was based on data that have been used
in our earlier estimation of the risk of CVD death in
Russia associated with current smoking [24]. We used a
proportional hazard model to calculate separate hazard ra-
tios for the three ranges of ages at baseline: 15 to 49, 50 to
64, and 65 and older. We also modeled the time profile of
the decline in the excessive risk of CVD death after the
elimination of smoking [25]. The calculation method is
described in detail in Appendix S1 (Additional file 3).
Results
Table 1 shows the age and education adjusted preva-
lence of current smoking by survey year for men and
women for each study. We excluded from this table
those studies that had a narrow age range (IFS1 and
IFS2, SAGE, SAHR), as a statistical adjustment for age
would not yield comparable estimates. As the RLMS is
an annual panel study using broadly consistent method-
ology throughout, estimates are shown in a separate col-
umn. Overall there is consistency in the trends seen
between RLMS and the other studies. Over most of the
period studied the age and educational adjusted preva-
lence of current smoking among men in the Russian
studies was relatively stable at around 60% (+/− 3%).From 2009 to 10 there was a suggestion of a decline,
with only GATS being an outlier. Importantly, the re-
markable reduction to 48% shown in RLMS in 2016 is
supported by the findings from two other studies, one of
which (VCIOM) had national coverage like RLMS. How-
ever, it is notable that the male prevalence even in this
most recent year in Russia was much higher than seen
in the comparator studies from the UK and USA.
The prevalence of current smoking among women in
Russia every year was appreciably lower than in men
(Table 1). Across the entire period shown in the RLMS
data, there has been a steady increase from around 11%
to a high of 19% in 2014. The estimates from the ad hoc
surveys for women are generally higher than from the
RLMS, with the exception of the Monitoring AH study,
again with a suggestion of slightly higher levels after
2009/10. The most recent Russian studies show a preva-
lence in women that is very similar to that seen in the
comparator studies from the UK and the USA.
Figure 1 shows the relationship of age to smoking
prevalence for men and women separately in different
rounds of the RLMS (upper panels) and in the various
other studies (lower panels) adjusted for education. In
men (left panels) there is a steep increase from adoles-
cence that peaks around the age of 25 years, with a sub-
sequent decline across midlife ages that becomes
particularly steep above the age of 60 years. This pattern
is almost identical across all the Russian studies, even
though there is a downward shift in the prevalence
curves for the studies conducted in the most recent
years. Other than among the oldest, the prevalence in
Russian men is far higher at every age than that in the
comparator studies from the UK and the U.S.
Among women Fig. 1 (right panels) also shows a peak
prevalence in the early 20s followed by a decline. In the
RLMS the prevalence above age 70 is almost zero with
the exception of the most recent round in 2016. In Fig. 1
women show a much more diverse range of prevalence
values across studies compared to men. Above the age
of 55 years among women, the comparator estimates
from the USA and UK are higher than at any RLMS
round or another Russian study. At younger ages below
35 years the comparator studies, particularly NHANES,
show lower prevalence than seen at any point among
Russian women.
Figure 1 also shows in more detail the way that smok-
ing prevalence at different age groups has changed over
time. For men, it is clear that the lowest prevalence at al-
most every age was for the most recent year (2016). In
contrast, the lowest levels for women in RLMS were
seen for the earliest round (1996). For women, it is evi-
dent that at younger ages the peak prevalence was in
2007, with prevalences under the age of 45 years falling
since then. The relatively complex changes over time
Table 1 Age-and-education standardized prevalence of current smoking in RLMS rounds and ad hoc surveys a
Central
year
Study Males (%) Females (%)
Ad hoc RLMS Ad hoc RLMS
1985 LRC/MONICA (1975–2002) 58.2 (1.3)b 18.4 (0.9)
1996 RLMS 62.5(2.8) 12.1 (0.7)
1998 RLMS 60.8 (2.8) 12.3 (0.7)
2000 RLMS 61.0 (2.9) 14.1 (0.8)
2000 Arkhangelsk study (2000) 56.2 (3.2) 22.6 (1.3)
2001 RLMS 61.9 (2.9) 15.4 (0.8)
2001 LLH (2001) 63.0 (3.8) 17.9 (0.6)
2002 RLMS 63.4 (2.9) 16.6 (0.9)
2003 RLMS 61.9 (2.9) 16.2 (0.9)
2004 RLMS 62.0 (2.9) 18.0 (1.0)
2005 RLMS 61.6 (3.0) 17.6 (1.0)
2006 RLMS 62.5 (2.6) 18.7 (0.9)
2006 Monitoring AH (2003–2010) 52.3 (0.8) 8.7 (0.1)
2007 RLMS 62.9 (2.7) 18.8 (0.9)
2008 RLMS 60.6 (2.7) 18.7 (0.9)
2009 RLMS 58.8 (2.6) 17.8 (0.9)
2009 GATS (2009) 62.5 (2.0) 22.8 (0.9)
2010 RLMS 56.5 (1.9) 17.9 (0.6)
2010 HITT (2010–2011) 56.6 (4.1) 23.5 (1.5)
2013c RLMS 53.3 (1.8) 17.5 (0.6)
2014 RLMS 52.3 (1.8) 17.8 (0.6)
2015 RLMS 48.6 (1.5) 17.3 (0.7)
2016 RLMS 48.1 (1.9) 17.5 (0.7)
2016 KYH (2015–2017) 48.6 (1.6) 22.2 (0.9)
2016 VCIOM (2016–2017) 48.7 (2.2) 21.3 (1.4)
2016 NHANES (2015–2016) 24.2 (1.1) 15.4 (0.7)
2012 HSE (2012) 23.4 (1.1) 19.2 (0.7)
Abbreviations: LRC/MONICA Lipid Research Clinics and MONItoring trends and determinants in CArdiovascular disease, LLH Living conditions, Lifestyle, and Health,
IFS 1 and IFS 2 Izhevsk Family Studies 1 and 2, Monitoring AH Monitoring of Arterial Hypertension in the Russian Federation, SAHR Stress Aging and Health in
Russia, SAGE WHO Study on global AGEing and adult health, GATS WHO Global Adult Tobacco Survey, HiTT Health in Times of Transition, KYH Know Your Heart
study, VCIOM “Healthy lifestyle monitoring” of the All-Russia Center for Studying Public Opinion, RLMS Russian Longitudinal Monitoring Survey, NHANES National
Health And Nutrition Examination Survey, HSE Health Survey for England
aFour surveys that include only younger ages under 60 (IFS1 and IFS2) and only older ages above 50–55 (SAGE and SAHR) are not shown in this table. They are
included in the analyses of age-specific data and in the regression models
bStandard errors are given in parentheses
cRLMS rounds of 2011 and 2012 are excluded from our analyses for a reason explained in the text (section "Data sets" in the "Methods")
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other studies (lower panels of Fig. 1), although it is not-
able that for men the two studies with some of the low-
est prevalences at each age are VCIOM and KYH, both
of which relate to the most recent period 2015–17. Time
trends by age group for RLMS are shown in Figure S1
(Additional file 4).
We now turn to look at the impact of education on
current smoking. The age-standardized prevalence of
current smoking by year and education in RLMS is
shown in Fig. 2 for men and women separately. For men
in all education groups, there has been a decline inprevalence after 2007. The visual impression is con-
firmed by statistically significant negative meta-
regression coefficients. For women, there is no evidence
of a decline in any educational group. On the contrary,
in the secondary and lower groups, there have been in-
creases, with these being throughout the whole period
for the lower group. Because of these different trends, it
is clear that over time there has been the emergence of a
considerable educational gradient in current smoking
among women in the whole period since the mid-1990s.
This is demonstrated in Fig. 3, where the odds ratios for
being a current smoker in low (vs high) educational
Fig. 1 Age-specific prevalence of current smoking adjusted for education in Russian and international surveys
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been a substantial increase in ORs over time from levels
1 to 1.5 in the 1990s to about 3.5 to 4 in the mid-2010s.
For men, there is a surprising degree of stability in the
ORs at around 3.5 to 4 since 1996. This difference be-
tween the two sexes is underlined by the difference in
the amount of heterogeneity I2 which is almost 80% for
women, but just 4% for men.
Figure 4 shows that the growing importance of educa-
tion as a factor of female smoking is entirely driven by
smoking at ages under 55. Whereas the OR (higher vs.Fig. 2 Age-standardized prevalence of smoking in RLMS by education and
levels for the linear trends’ slopes from meta-regression are shown on thelower education) remains almost unchanged across
RLMS rounds at ages 55+, it sharply increases with time
at ages 18 to 54 years.
A parallel analysis looking at the magnitude of the
ORs for current smoking by education based on the
other surveys is broadly consistent with what we have
seen in Figs. 3 and 4 using RLMS. As can be seen in Fig-
ure S2 (Additional file 5), the ORs are more stable for
men compared to women, where the ORs vary consider-
ably between surveys even when they are conducted in
similar periods. In addition, there is only evidence of anfor the total population in 1996–2016. Note. Values and significance
panels
Fig. 3 Educational differences in smoking (ORs low vs. high) adjusted for age in RLMS, 1996–2016
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55 years (Figure S3 in Additional file 6).
Overall, from our analyses, we have found roughly a
10% decline in the prevalence of current smoking in
men in the period 2008–2016. Based on this figure, we
estimated the number of male cardiovascular disease
(CVD) deaths that might have been avoided because of
this positive change. CVD is an appropriate focus be-
cause it is the only major group of causes of death where
risk rapidly falls to that of non-smokers. We estimate
that some 48 thousand CVD deaths were avoided among
men compared to a “business as usual” regime in 2008–
2016. Of these, 79% would have been under the age of
65 years. This constitutes 1.0% of all deaths during the
same nine years under the mortality regime of 2007,
1.3% of all deaths observed in reality in these years, and
6.2% of the reduction in deaths (compared to the mor-
tality regime of 2007) in the observed deaths.
Discussion
Our novel synthesis of existing data on current smoking
prevalence in Russia has shown that for men, the period
since 2008 has seen a simultaneous decline in all age
groups. This decline is remarkable since it was preceded
by a period of many decades where smoking prevalence
in men remained almost static at every age. This decline
in prevalence has occurred regardless of educational
level.Among women, the increase in smoking prevalence at
younger ages appears to have now reversed in the most
recent years. However, at older ages, an upward trend
remains. These two countervailing trends appear to re-
sult in an overall stabilization of the trend for women as
a whole. Unfortunately, educational differences in
current smoking among women show very divergent
trends, with those with the highest levels of education
showing small declines, whereas those women with min-
imal educational attainment have shown a persistent
steady increase, resulting in the emergence of a pro-
nounced inverse educational gradient over the last two
decades.
Over the past 30 years, smoking in Russia has shown
distinctive features that are radically different from those
observed in most Western European countries and
North America. While smoking prevalence among men
has been declining for decades in nearly all high-income
countries, in Russia it has been relatively stable. In 2015,
WHO projected that male smoking would decline to
54% in 2025 using 3 surveys conducted in the 2000s
[26]. Our findings suggest that the decline is underway
and that male smoking was below 50% already in 2015–
2016. Nevertheless, today the prevalence of current
smoking in Russia under the age of 60 years is still far
higher than seen in the UK and the USA.
The other distinctive feature is that in the past women
in Russia had far lower rates of smoking compared to
Fig. 4 Educational differences in female smoking (ORs low vs. high) by age group in RLMS, 1996–2016
Shkolnikov et al. BMC Public Health          (2020) 20:378 Page 8 of 11their counterparts in most Western countries [26]. How-
ever, it is known that, since the 1990s, the prevalence of
smoking among younger women has been increasing [9].
Our analyses show that compared to current smoking
prevalence in the UK and the U.S. up to the age of 45–
50, smoking among Russian women is appreciably
higher, with the historic low rates remaining confined to
older generations.
It is not possible in this analysis to formally evaluate
how far the changes in smoking behavior we have found
are attributable to the major policy innovations in smok-
ing control introduced in Russia over the past 10 years.
A change in smoking prevalence in a population repre-
sents the combined effects of three factors, initiation,
quitting, and selective mortality. In the absence of long-
term cohort data, it is impossible to determine with con-
fidence the precise role that each of the three factors
plays. Nevertheless, a substantial decrease both in male
and female smoking around age 20 between 2007 and
2016, suggests a lower rate of initiation in younger co-
horts (Fig. 1, upper panels). Considerable decreases in
smoking of men at ages 30 to 50 and women at ages 30
to 40 may be associated with quitting. These changes in
initiation and quitting may have been catalyzed by the
policy changes. On the other hand, the rise of smoking
among older women may reflect the counter-balancing
forces of aggressive marketing by the transnational to-
bacco industries who saw in the 1990s an unexploitedmarket among Russian women among whom smoking
had previously been socially stigmatized [27].
Selective mortality may provide at least a partial ex-
planation of the very pronounced decline in the preva-
lence of current smoking across ages among males that
we have seen. The long-term hazard of death among
smokers is about twice that of non-smokers. A simple
model we have built (not shown here) suggests that the
lower survival of smokers could produce a reduction in
the observed cross-sectional prevalence in Russia be-
tween ages 25 and 75 of about one quarter. This select-
ive attrition of smokers after age 60 years is particularly
pronounced, with half of the rapid decrease in male
smoking with age being explained by the high mortality
of smokers. This effect would have been particularly
pronounced among those who were aged 50 and older
in the mid-1990s and who passed through the period of
extremely high mortality (“crisis mortality”) in the 1990s
and the early 2000s. In contrast among women, because
prevalence has been so low, the pattern of smoking from
younger to older ages depends mostly on the historical
increase in female smoking across generations i.e. cohort
increases in smoking.
What is clear is that the policies adopted, focused on
price and marketing, are soundly evidence-based and the
declines among men have occurred at the same time as
their implementation. For younger women, the market
downturn in prevalence has also coincided with these
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that the tobacco epidemic starts to recede among
women overall, in the short and medium-term it will be
important to concentrate on measures that encourage
people to quit, such as steadily increasing taxes.
In this paper, we have shown that there is consistency
across different studies in patterns of smoking behavior
among men. This applies to absolute levels, age-patterns,
recent declines, and educational gradients. This finding
is striking because the studies that were included have a
range of designs, sampling frames and were conducted
at various points across nearly three decades. This repli-
cation of the same pattern provides confidence that in
broad terms what we have observed is robust. The sta-
bility of patterns seen for men regardless of the survey is
notable given the geographic dispersion of the studies.
This suggests that there is a geographic homogeneity in
the principal patterns of male smoking across the whole
of Russia, although the pronounced educational gradi-
ents show that smoking among men in the past 20–30
years is not uniform across socio-economic strata.
The situation among women is rather different. We have
found a considerably greater heterogeneity in findings
across surveys than seen among men. These variations are
unlikely to be due to differences in design or sampling
frame as the more consistent estimates seen for men are
based on the same set of studies. Instead, it is likely to re-
flect greater geographic variation in smoking behavior
among women, consistent with previous analyses that have
shown the steepest smoking increases in the large metro-
politan centers of Moscow and St Petersburg [9].
In the 1980s and the 1990s, the prevalence of male smok-
ing showed strong educational differences, with the highest
levels in the least educated. In comparison among women,
educational differences in smoking were initially small but
have widened over time. The declines in smoking among
men in Russia appear to have occurred in all educational
groups. This is the same as has been observed in a diverse
range of Western European countries [28] and Canada
[29], although unlike in Russia, some other countries have
seen the largest declines among the most educated men. In
women, the Russian trend of increasing educational differ-
ences, driven primarily by increases in prevalence among
low educated women is similar to that seen in Western
Europe [28] and in Estonia [30], a former Soviet country.
Even in the 2010s, age-adjusted smoking did not decrease
significantly among Russian women with high education,
and it continued to increase in women with low and sec-
ondary education.
It has long been assumed that the heavy burden of smok-
ing among men in Russia contributes substantially to the
high levels of mortality. For example, using indirect
methods, it was estimated that in the year 2000 smoking
accounted for 26% of deaths among men. In contrast, theequivalent figure for women was just 3% [31]. What is crit-
ical, from a public health perspective, is that individual-level
risk of mortality from cardiovascular disease among
smokers greatly reduces within a short time after quitting.
After 5 years the excessive risk reduces by about 70% and
the risk returns to that of non-smokers within 10 years of
quitting [25, 32]. This means that declines in smoking
prevalence can be expected to have relatively rapid positive
effects on the rate of cardiovascular events and deaths in a
population. To this extent, the recent decline in smoking
among men is already likely to have contributed to the de-
cline in CVD mortality among men in Russia since the late-
2000s. Our estimates show that the absolute number of
avoided male deaths in 2008–2016 is quite large 48,000, al-
though this constitutes only about 6% of the observed de-
crease in CVD deaths. Most importantly, maintaining this
decline in current smoking will contribute much more to
future decreases in CVD, cancers and other diseases. How-
ever, the declines in CVD mortality among women that
have been seen, particularly at older ages, are almost cer-
tainly unrelated to smoking, as trends are in the opposite
direction. Moreover, the relatively low prevalence of smok-
ing at older ages in women, where CVD mortality rates are
highest, means that smoking among women cannot explain
any of the differences in CVD mortality with other coun-
tries such as the UK and the USA.
Conclusion
The implementation of an effective tobacco control
strategy in Russia starting in 2008 coincided with a de-
cline in smoking prevalence among men regardless of
education from what had been a long-term high and
stable level of current smoking. Among women, the de-
clines have been more uneven, with young women
showing recent downturns, while the prevalence among
those in middle age is increasing, particularly among
those with minimal education. Among men, these posi-
tive changes will have made a small contribution to the
reduction in mortality seen in Russia since 2005.Supplementary information
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